1. Home
  2. URG vs FLGT Comparison

URG vs FLGT Comparison

Compare URG & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ur Energy Inc (Canada)

URG

Ur Energy Inc (Canada)

HOLD

Current Price

$0.75

Market Cap

608.7M

ML Signal

HOLD

Logo Fulgent Genetics Inc.

FLGT

Fulgent Genetics Inc.

HOLD

Current Price

$19.73

Market Cap

511.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
URG
FLGT
Founded
2004
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Medical Specialities
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
608.7M
511.0M
IPO Year
2006
2016

Fundamental Metrics

Financial Performance
Metric
URG
FLGT
Price
$0.75
$19.73
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
★ $2.11
N/A
AVG Volume (30 Days)
★ 12.0M
245.8K
Earning Date
11-17-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $27,207,000.00
$18,730,000.00
Revenue This Year
$142.81
$2.80
Revenue Next Year
$80.08
$15.38
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.72
$13.46
52 Week High
$2.15
$31.04

Technical Indicators

Market Signals
Indicator
URG
FLGT
Relative Strength Index (RSI) 29.93 40.00
Support Level N/A $19.34
Resistance Level $1.46 $20.02
Average True Range (ATR) 0.06 0.84
MACD 0.00 -0.12
Stochastic Oscillator 5.86 11.76

Price Performance

Historical Comparison
URG
FLGT

About URG Ur Energy Inc (Canada)

Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project; Shirley Basin; Other U.S. Projects.

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.

Share on Social Networks: